Validation of the cross-cultural dementia screening test in Alzheimer’s disease and Parkinson’s disease

Validation of the cross-cultural dementia screening test in Alzheimer’s disease and Parkinson’s disease
Front Psychol. 2023 Jan 4;13:1043721. doi: 10.3389/fpsyg.2022.1043721. eCollection 2022.ABSTRACTOBJECTIVE: The Cross-Cultural Dementia (CCD) is a new screening tool to evaluate cognitive impairment based on a cross-cultural perspective to reduce the bias of education, and language and cultural differences. We aimed to evaluate the diagnostic properties of the CCD in Spaniards for the assessment of patients with Alzheimer's disease in mild ... read more
Source: PubMedPublished on 2023-01-23By Alfonso Delgado-Álvarez